Publikationen in Zusammenarbeit mit Forschern von University of California, San Francisco (9)

2022

  1. Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 3, pp. 282-293

  2. Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib

    npj Precision Oncology, Vol. 6, Núm. 1

  3. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients

    The Lancet. Oncology, Vol. 23, Núm. 1, pp. 149-160

2011

  1. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer

    JAMA - Journal of the American Medical Association, Vol. 305, Núm. 18, pp. 1873-1881